FIRESIDE CHAT WITH BRENT AHERNS -Canaan Partner, MedTech Serial Success

This is an online event. Participation is 100% online.

Participants can be located anywhere in the world.

This event is FREE to attend.

Participants must register via Eventbrite.

Participants who have registered via Eventbrite will be emailed the login link right before the start of the event.

A “YES” RSVP on our meetup site does not confirm your reservation.

Space is limited. Please only RSVP “Yes” if you will be attending.

In order to participate, you must register here: https://www.eventbrite.com/e/fireside-chat-with-brent-aherns-canaan-partner-medtech-serial-success-tickets-151116141447

Hurry! Slots are limited!

ABOUT THIS EVENT
Life Science and HealthTech Entrepreneurs invites you our next Fireside Chat—a rare “Unleashed” Fireside with Silicon Valley Mastermind Brent Ahrens.

Our esteemed guest for this installation is Brent Aherns, General Partner at Canaan Partners, one of the hottest, most innovative and sought-after venture capital firms in Silicon Valley. Several of Brent’s prior investments are well known: Calixa Therapeutics (acquired by Cubist Pharmaceuticals), Cerexa (acquired by Forest Labs), Data Sciences International (acquired by Harvard Bioscience), DexCom (IPO), Durata Therapeutics (IPO), Elevation Pharmaceuticals (acquired by Sunovion Pharmaceuticals), Peninsula Pharmaceuticals (acquired by Johnson & Johnson), Revivant (acquired by ZOLL), Spinifex Pharmaceuticals (acquired by Novartis).

Our Moderator for the event, Roger Rappoport, is the leader of Procopio’s Emerging Growth and Venture Capital practice group. Roger is the founder of Access Silicon Valley (ASV) and Life Sciences and HealthTech Entrepreneurs (LSAHTE). He will take the audience through a discussion of the following topics:

• The most efficient and effective ways to raise capital in today’s environment,
• The do’s and don’ts of fundraising,
• Building and scaling a company including curating an attractive company culture, from both the investors’ and founder’s perspective.

Biotechnology, pharmaceutical, medical device, genomics or diagnostics start-up as well as early stage entrepreneurs will gain a practical perspectives and insight into:

• The fundraising process,
• What investors are looking for,
• How to reach them,
• What entrepreneurs need to do (and not do) to get a meeting and raise a successful round,
• Common early stage mistakes that entrepreneurs make that can impact fundability.

Join Life Sciences and HealthTech Entrepreneurs for this interactive, audience-driven morning of insights from the poised vantage one of the most interesting and inspiring leaders who’s made it BIG in California!

AGENDA
12:00PM – 12:15PM – Speaker Introductions
12:15PM – 2:00PM – Fireside Discussion
2:00PM – 2:30PM – Audience Q & A

SPEAKER BIOs

Brent Aherns is Brent leads investments in an array of healthcare companies, with a focus on biopharma and med tech. He joined Canaan in 1999 as a member of the Kauffman Fellows Program. Brent focuses on healthcare investments and has led investments in life sciences companies such as DexCom (DXCM), Revivant (acquired by ZOLL), Peninsula Pharmaceuticals (acquired by JNJ), Cerexa (acquired by FRX), Calixa (acquired by CBST), Durata Therapeutics (DRTX), Elevation Pharmaceuticals (acquired by DNPUF); and Spinifex (acquired by NVS).

About Canaan
Canaan is an early-stage venture capital firm that invests in visionaries with transformative ideas. While we love speedy success, we’re acutely aware that greatness comes in many forms and at different times. That’s why we’re not afraid to break the mold to bring something spectacular to life.

Roger Rappoport is the founder and leader of Procopio’s Emerging Growth and Venture Capital Practice Group.

He has extensive experience in advising startup and well-established emerging growth companies, primarily in the software, information technology, Internet, fixed and mobile communications technology, cleantech and life sciences sectors.